These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22387674)

  • 21. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
    J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
    Quesada A; Micevych PE
    J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease.
    Baraka AM; Korish AA; Soliman GA; Kamal H
    Life Sci; 2011 May; 88(19-20):879-85. PubMed ID: 21420980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation.
    Yi KD; Cai ZY; Covey DF; Simpkins JW
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1188-95. PubMed ID: 18089844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Bourque M; Morissette M; Di Paolo T
    Neurobiol Aging; 2014 Oct; 35(10):2347-56. PubMed ID: 24726471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease.
    Côté M; Bourque M; Poirier AA; Aubé B; Morissette M; Di Paolo T; Soulet D
    Neurobiol Dis; 2015 Oct; 82():99-113. PubMed ID: 26051538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model.
    Choi JS; Lee MS; Jeong JW
    Biochem Biophys Res Commun; 2010 Apr; 394(3):854-8. PubMed ID: 20307492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.
    Gillies GE; McArthur S
    Horm Behav; 2010 Jan; 57(1):23-34. PubMed ID: 19538962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
    Sagi Y; Mandel S; Amit T; Youdim MB
    Neurobiol Dis; 2007 Jan; 25(1):35-44. PubMed ID: 17055733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
    Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W; Sripanichkulchai K; Finkelstein DI
    Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of astrocytes in the neuroprotective actions of 17β-estradiol and selective estrogen receptor modulators.
    Acaz-Fonseca E; Sanchez-Gonzalez R; Azcoitia I; Arevalo MA; Garcia-Segura LM
    Mol Cell Endocrinol; 2014 May; 389(1-2):48-57. PubMed ID: 24444786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease.
    Kreisler A; Duhamel A; Vanbesien-Mailliot C; Destée A; Bordet R
    Behav Pharmacol; 2010 May; 21(3):194-205. PubMed ID: 20440202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
    Miller DB; Ali SF; O'Callaghan JP; Laws SC
    Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
    Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
    J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Ca2+ channel modulation in the neuroprotective actions of estrogen in beta-amyloid protein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxic models.
    Ba F; Pang PK; Benishin CG
    Neurochem Int; 2004 Jul; 45(1):31-8. PubMed ID: 15082219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.